Drug Utilization Study in Patients of Chronic Suppurative Otitis Media Patients Attending a Government Tertiary Care Hospital in Jaipur City
Keywords:
Chronic Suppurative Otitis Media, Prescribing Trends, Antimicrobials, Drug Utilization Pattern.Abstract
Background: Chronic Suppurative Otitis Media (CSOM) remains a significant public health problem in developing countries, including India, contributing to morbidity, hearing impairment, and decreased quality of life. The rational use of antimicrobials and adjunctive medications plays a crucial role in the effective management of CSOM and in preventing antimicrobial resistance.
Objectives: To analyze the prescribing patterns of antimicrobials and other drugs in patients diagnosed with CSOM attending the outpatient department of a government tertiary care hospital in Jaipur City.
Methods: A prospective, cross-sectional observational study was conducted over a period of six months among patients clinically diagnosed with CSOM. Drug utilization pattern was analyzed to identify the frequently prescribed antimicrobials and other therapeutic drug classes.
Results: The majority of patients were in the [31–45 years], with a slight predominance of females. Oral antimicrobials were the most frequently prescribed drugs, followed by systemic antibiotics such as ciprofloxacin. Adjunctive drugs included antihistamines, nasal decongestants, and analgesics. Polypharmacy was minimal, and adherence to the essential drug list prescribing was noted in all the cases
Conclusion: The prescribing pattern in CSOM patients at this tertiary care hospital showed a preference for antimicrobials like fluoroquinolones and beta lactams. The predominance of oral drug use supports patient compliance and ease of use. However, continuous monitoring, adherence to treatment guidelines, and judicious antimicrobial use are essential to curb resistance and ensure optimal patient outcomes.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.



